Clinical Trial Update: A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure [Phase 1]

View source ↗

Summary

Phase 1 double-blind pharmacokinetic study to evaluate whether a single IV infusion of GGF2 or placebo alters midazolam pharmacokinetics in patients with Heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• GGF2 (glial growth factor 2)
• Midazolam (Midazolam)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Heart Failure | Phase 1 | Status: COMPLETED